Skip to content
Gigantum.net
Tech

Science & space

1,131 stories

Science & space

T-Mobile CEO dismisses Starlink Mobile threat.

Srini Gopalan in response to SpaceX saying it plans to “acquire quite a few” of T-Mobile, AT&T, and Verizon’s customers by turning Starlink dishes into tiny cellular base stations using the limited spectrum it acquired from EchoStar: > You’ve got to ask the question of ‘What is the gap in the market that they’re looking to serve? I always prefer starting these conversations back from the customer: Why would a customer buy a new cellular service? Where do they go? What’s their differentiation? It’s clearly not having a broad network. [Link: Starlink mobile threat has been exaggerated, says T-Mobile CEO | https://www.ft.com/content/5d6b7dcf-fe0e-4cb1-ad1d-0157407296cc | Financial Times]

Science & space

Google DeepMind says its AI model can predict tropical cyclones sooner.

The company shared research about how its WeatherNext AI model can predict a cyclone’s track, intensity, and wind structure up to 15 days in advance, giving “forecasters an extra day’s worth of predictive accuracy.” [Link: AI model achieves breakthrough in forecasting cyclones | https://deepmind.google/blog/weathernext-ai-model-achieves-breakthrough-in-forecasting-cyclones/ | Google DeepMind]

Science & space

Elon Musk’s Terafab will be built — where else? — in Texas.

The massive $16.8 billion chip facility, which is being built by Tesla and SpaceX with help from Intel, will be located in Grimes County, population 29,268. After securing over a billion dollars in tax breaks from two rural school districts, SpaceX says it will break ground later this year. The fab will supply AI chips to power Musk’s plans to build a “robot army” that includes self-driving cars and humanoid robots, as well as for the data centers he plans on launching into space. [Media: https://twitter.com/Tesla/status/2085365278276284803?s=20]

Science & space

FDA approves first mRNA flu vaccine from Moderna.

Despite the preferences of some, Moderna announced that after years of work, mFLUSIVA (mRNA-1010) has been approved for use in adults aged 50 to 64, with an accelerated approval for adults 65 and up as they wait for the results of a follow-up study. While Moderna plans to roll it out by this fall, the WSJ notes it’s still unclear what RFK Jr.‘s vaccine recommendation panel will say about this use of the Nobel Prize-winning approach. [Link: F.D.A. Approves Moderna’s mRNA Flu Vaccine | https://www.nytimes.com/2026/08/05/health/mrna-flu-vaccine-moderna.html? | The New York Times]

Saturday, October 10, 2026

© 2026 Gigantum.net. Content gathered automatically from external sources; rights to each text belong to whoever originally published it.